These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38180008)

  • 1. Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.
    Dong C; Yu X; Jin K; Qian J
    Nanomedicine (Lond); 2023 Dec; 18(30):2161-2184. PubMed ID: 38180008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment.
    Mendes M; Nunes S; Cova T; Branco F; Dyrks M; Koksch B; Vale N; Sousa J; Pais A; Vitorino C
    Colloids Surf B Biointerfaces; 2024 Sep; 241():113983. PubMed ID: 38850741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming biological barriers BBB/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapy.
    Zwain T; Alder JE; Zwayen S; Shaw A; Burrow AJ; Singh KK
    Biomater Adv; 2023 Dec; 155():213660. PubMed ID: 37976832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
    Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
    J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
    Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
    Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
    Ter Linden E; Abels ER; van Solinge TS; Neefjes J; Broekman MLD
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.
    Balça-Silva J; Matias D; Carmo AD; Sarmento-Ribeiro AB; Lopes MC; Moura-Neto V
    Semin Cancer Biol; 2019 Oct; 58():130-141. PubMed ID: 30266571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
    Martins C; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
    Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
    Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A state-of-the-art liposome technology for glioblastoma treatment.
    Hasan I; Roy S; Ehexige E; Wu R; Chen Y; Gao Z; Guo B; Chang C
    Nanoscale; 2023 Nov; 15(45):18108-18138. PubMed ID: 37937394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model.
    Lakkadwala S; Singh J
    J Pharm Sci; 2018 Nov; 107(11):2902-2913. PubMed ID: 30055226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
    Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
    Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized liposomes: an enticing nanocarrier for management of glioma.
    Peddinti V; Rout B; Agnihotri TG; Gomte SS; Jain A
    J Liposome Res; 2024 Jun; 34(2):349-367. PubMed ID: 37855432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.